DK1012286T3 - Allelvariant af humant STAT3 - Google Patents

Allelvariant af humant STAT3

Info

Publication number
DK1012286T3
DK1012286T3 DK98951396T DK98951396T DK1012286T3 DK 1012286 T3 DK1012286 T3 DK 1012286T3 DK 98951396 T DK98951396 T DK 98951396T DK 98951396 T DK98951396 T DK 98951396T DK 1012286 T3 DK1012286 T3 DK 1012286T3
Authority
DK
Denmark
Prior art keywords
human stat3
allele variant
human
stat3
variant
Prior art date
Application number
DK98951396T
Other languages
English (en)
Inventor
Ottaviano Serlupi-Crescenzi
Pietra Linda Della
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP97116061A external-priority patent/EP0906953A1/en
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK1012286T3 publication Critical patent/DK1012286T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4702—Regulators; Modulating activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Toxicology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Transplantation (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pyridine Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
DK98951396T 1997-09-16 1998-09-15 Allelvariant af humant STAT3 DK1012286T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP97116061A EP0906953A1 (en) 1997-09-16 1997-09-16 Allelic variant of human stat3
EP98102774A EP0905234A3 (en) 1997-09-16 1998-02-18 Allelic variant of human STAT3
PCT/EP1998/005844 WO1999014322A2 (en) 1997-09-16 1998-09-15 Allelic variant of human stat3

Publications (1)

Publication Number Publication Date
DK1012286T3 true DK1012286T3 (da) 2007-02-12

Family

ID=26145781

Family Applications (1)

Application Number Title Priority Date Filing Date
DK98951396T DK1012286T3 (da) 1997-09-16 1998-09-15 Allelvariant af humant STAT3

Country Status (10)

Country Link
US (2) US6369198B1 (da)
EP (2) EP0905234A3 (da)
JP (1) JP2001516578A (da)
AT (1) ATE343633T1 (da)
AU (1) AU9743698A (da)
DE (1) DE69836278T2 (da)
DK (1) DK1012286T3 (da)
ES (1) ES2272010T3 (da)
PT (1) PT1012286E (da)
WO (1) WO1999014322A2 (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6391572B1 (en) * 1999-08-31 2002-05-21 The Rockefeller University Methods for identifying modulators of transcriptional activator protein interactions
US7094140B2 (en) * 2003-06-03 2006-08-22 Onfloor Technologies, L.L.C. Abrasive sanding surface
US20060148715A1 (en) * 2004-12-20 2006-07-06 Baylor College Of Medicine Structural requirements for STAT3 binding and recruitment to phosphotyrosine ligands
JP5495249B2 (ja) 2009-02-23 2014-05-21 富士通株式会社 新規化合物、リン酸化阻害剤、インスリン抵抗性改善剤、及び糖尿病の予防乃至治療剤、並びに、スクリーニング方法
WO2011163423A2 (en) * 2010-06-22 2011-12-29 University Of Central Florida Research Foundation, Inc. Methods and compositions for cell permeable stat3 inhibitor
WO2013000872A2 (en) * 2011-06-27 2013-01-03 Galderma Research & Development New th-17 differentiation markers for rosacea and uses thereof
BR112021005464A2 (pt) * 2018-08-15 2021-06-29 The Regents Of The University Of California inibição de il-10 para vacinas e imunoterapia

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU8072194A (en) * 1993-09-24 1995-04-10 Rockefeller University, The Receptor recognition factors, protein sequences and methods of use thereof
EP0676469A3 (en) * 1994-04-04 1998-03-25 Tadamitsu Kishimoto Transcription Factor APRF
US5716622A (en) * 1995-01-06 1998-02-10 The Rockefeller University Functionally active regions of signal transducer and activators of transcription

Also Published As

Publication number Publication date
US6660848B2 (en) 2003-12-09
EP1012286A2 (en) 2000-06-28
AU9743698A (en) 1999-04-05
DE69836278D1 (de) 2006-12-07
PT1012286E (pt) 2006-12-29
JP2001516578A (ja) 2001-10-02
WO1999014322A3 (en) 1999-08-05
US6369198B1 (en) 2002-04-09
DE69836278T2 (de) 2007-09-13
ES2272010T3 (es) 2007-04-16
ATE343633T1 (de) 2006-11-15
WO1999014322A2 (en) 1999-03-25
EP0905234A2 (en) 1999-03-31
EP0905234A3 (en) 1999-06-23
EP1012286B1 (en) 2006-10-25
US20030166854A1 (en) 2003-09-04

Similar Documents

Publication Publication Date Title
ATE232396T1 (de) Oxydiertes thymosin beta 4
ATE322505T1 (de) Tgf-g beta inhibitor-peptide
WO1996034953A3 (en) Cd16-ii variants
FI963101L (fi) Anti-TNF-vasta-aineiden käyttö lääkkeenä sellaisten sairauksien hoitoon, joissa seerumin interleukiini-6-taso on kohonnut
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DE69905170T2 (de) Thiazolopyrimidinderivate
NO20006113D0 (no) Anvendelse av cyklosporiner i behandlingen av inflammatoriske autoimmune sykdommer
IS2819B (is) Viðloðunarsameindir í æðum og mótun á starfsemi@þeirra
DE59204364D1 (de) Zahnärztlicher Patientenstuhl.
DK1012286T3 (da) Allelvariant af humant STAT3
EP1224201A4 (en) 32 HUMAN SECRETED PROTEINS
IT1286663B1 (it) Proteina capace di inibire l'attivita' ribosomiale,sua preparazione ed uso come immunoconiugato chimico o ricombinante e sequenza di cdna
DE69831223D1 (de) Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
DE60119347D1 (de) Verwendung von chimäres il6-il6r in huntingtonskrankheit
EP1507523A4 (en) Cinnamic acid dimers, their preparation and their use in the treatment of neurodegenerative diseases
IS7868A (is) Notkun á kortkólíberín-úrókortín kerfi í meðferð á bólguvaldandi sjúkdómum.
PT1496884E (pt) Associacao de um antitrombotico e de aspirina e sua utilizacao no tratamento das doencas tromboticas aterosclerosas.
DE3777359D1 (de) Aminosaeuresequenz des menschlichen alpha 2-plasmininhibitors und cdns sowie diese aminosaeuresequenz codierende genomische dns.
DE59811703D1 (de) Medizinischer oder dentalmedizinischer Behandlungsstuhl
NO20006091D0 (no) Humant protein C-polypeptid
EP1549664A4 (en) MURINES ORTHOLOGY OF THE HUMAN DISRUPTED-IN SCHIZOPHRENIA 1-GENES
RU96103721A (ru) Антгельминтное средство
FI972637A0 (fi) K-ryhmän vitamiinin käyttö lisäkilpirauhasen liikatoiminnan hoitoon